The galectin-3 inhibitor selvigaltin reduces liver inflammation and fibrosis in a very substantial fat food plan rabbit model of metabolic-involved steatohepatitis Table four Statistical evaluation of dose proportionality in the pharmacokinetic parameters of GB1211 following solitary oral doses (a) and multiple oral doses (b) Springer Character or its licensor (e.g. https://felixibodt.blogripley.com/40028652/the-5-second-trick-for-selvigaltin-gb1211